|
|
Volumn 22, Issue 10, 2007, Pages 3087-
|
|
Cinacalcet, paricalcitol, or both? [3]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALFACALCIDOL;
CALCITRIOL;
CALCIUM;
CALCIUM PHOSPHATE;
CINACALCET;
PARATHYROID HORMONE;
PARICALCITOL;
PHOSPHORUS;
NAPHTHALENE DERIVATIVE;
VITAMIN D;
CALCIUM BLOOD LEVEL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
FOLLOW UP;
HEMODIALYSIS;
HEMODIALYSIS PATIENT;
HUMAN;
HYPERCALCEMIA;
HYPERPHOSPHATEMIA;
LETTER;
LOW DRUG DOSE;
MEDICAL PARAMETERS;
MORTALITY;
PARATHYROID HORMONE BLOOD LEVEL;
PHOSPHATE BLOOD LEVEL;
PRIORITY JOURNAL;
RISK REDUCTION;
SECONDARY HYPERPARATHYROIDISM;
BONE;
CHRONIC DISEASE;
DRUG COMBINATION;
HYPERPARATHYROIDISM;
KIDNEY DISEASE;
METABOLIC BONE DISEASE;
METABOLISM;
NOTE;
PRACTICE GUIDELINE;
RENAL REPLACEMENT THERAPY;
STANDARD;
STATISTICAL ANALYSIS;
BONE AND BONES;
BONE DISEASES, METABOLIC;
CHRONIC DISEASE;
DATA INTERPRETATION, STATISTICAL;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERPARATHYROIDISM;
KIDNEY DISEASES;
NAPHTHALENES;
PRACTICE GUIDELINES AS TOPIC;
RENAL DIALYSIS;
VITAMIN D;
|
|
EID: 36049042639
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfm423 Document Type: Letter |
|
Times cited : (1)
|
|
References (4)
|
